Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study evaluates how new magnetic resonance imaging (MRI) and artificial intelligence techniques improve the image quality and quantitative information for future prostate MRI exams in patients with suspicious of confirmed prostate cancer. The MRI and artificial intelligence techniques developed in this study may improve the accuracy in diagnosing prostate cancer in the future using less invasive techniques than what is currently used.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni w wieku 18 lat lub starsi
- •Podejrzenie raka prostaty lub potwierdzony rak prostaty po biopsji
- •Przeszedł/-ła lub przechodzi wieloparametryczne badanie MRI prostaty 3 T w UCLA
- •Możliwość udzielenia zgody na udział w badaniu
✗ Disqualifies
- •Przeciwwskazania do badania MRI (np. wszczepione urządzenia kardiologiczne, sztuczne zastawki, silna klaustrofobia)
- •Przeciwwskazania do stosowania środków kontrastowych z gadolinem, z wyjątkiem możliwości reakcji alergicznej na nie
- •Wcześniejsze leczenie radioterapią
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 7, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, United States
Trial contact
Nashla Barroso
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.